申请人:Armour Pharmaceutical Company
公开号:US03994891A1
公开(公告)日:1976-11-30
Tetrahydroisoquinoline compounds represented by the formula: ##SPC1## In which X is a hydroxy group, Y is a hydroxy group or Y taken with X is --O--CH.sub.2 --O--, Z is hydrogen or a hydroxy group, R.sub.1 is hydrogen or an alkyl group of one to four carbon atoms, R.sub.2 is hydrogen, an alkyl group of one to four carbon atoms or phenyl, pyrrolidinomethyl, piperidinomethyl, or morpholinomethyl, R.sub.3 and R.sub.4 each is an alkyl group of one to four carbon atoms or R.sub.3 taken with R.sub.4 and N is pyrrolidinyl, piperidino, morpholino, or 2-(1,2,3,4-tetrahydroisoquinolyl), and n is one or zero, Which compounds are effective as vasodilators, processes for the preparation of these compounds, and intermediate compounds useful in the preparation of such compounds.
化学式表示为:##SPC1## 的四氢异喹啉化合物:其中X是羟基,Y是羟基或与X一起取为--O--CH.sub.2 --O--,Z是氢或羟基,R.sub.1是氢或一个碳原子数为1至4的烷基,R.sub.2是氢,一个碳原子数为1至4的烷基或苯基,吡咯啉甲基,哌啶甲基或吗啉甲基,R.sub.3和R.sub.4各自是一个碳原子数为1至4的烷基,或R.sub.3与R.sub.4一起取为N是吡咯啉基,哌啶基,吗啉基或2-(1,2,3,4-四氢异喹啉基),n为一或零。这些化合物作为血管扩张剂有效,本发明涉及制备这些化合物的方法以及在制备这些化合物中有用的中间体化合物。